Cargando…

Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana

BACKGROUND: Botswana introduced the HBV vaccine at birth for all newborns in 2000. To the best of our knowledge, since the introduction of HBV vaccination, there have been limited data for vaccine response to HBV and its impact on early childhood HBV infections among children HIV exposed but uninfec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baruti, Kabo, Lentz, Kayla, Anderson, Motswedi, Ajibola, Gbolahan, Phinius, Bonolo B., Choga, Wonderful T., Mbangiwa, Tshepiso, Powis, Kathleen M., Sebunya, Theresa, Blackard, Jason T., Lockman, Shahin, Moyo, Sikhulile, Shapiro, Roger, Gaseitsiwe, Simani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413399/ https://www.ncbi.nlm.nih.gov/pubmed/32764801 http://dx.doi.org/10.1371/journal.pone.0237252

Ejemplares similares

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2020)

Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana
por: Phinius, Bonolo Bonita, et al.
Publicado: (2020)

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana
por: Choga, Wonderful Tatenda, et al.
Publicado: (2020)

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana
por: N’Guessan, Kombo F, et al.
Publicado: (2017)

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm
por: Anderson, Motswedi, et al.
Publicado: (2018)

Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2018)

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana
por: Mbangiwa, Tshepiso, et al.
Publicado: (2018)

Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study
por: Bhebhe, Lynnette, et al.
Publicado: (2019)

High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana
por: Baruti, Kabo, et al.
Publicado: (2023)

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2023)

Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2014)

High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana
por: Phinius, Bonolo B, et al.
Publicado: (2023)

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana
por: Ryan, Kathleen, et al.
Publicado: (2017)

Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana
por: Seatla, Kaelo K., et al.
Publicado: (2021)

Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2015)

Youth and healthcare workers’ perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana
por: Nambusi, Kyegombe, et al.
Publicado: (2023)

Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2016)

2572. Decreased T-Cell Response, but Appropriate Antibody Production to Tetanus Vaccine Among HIV-Exposed Uninfected Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2018)

Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations With 24-Month Growth and Neurodevelopment
por: Moraka, Natasha O, et al.
Publicado: (2020)

A25 Impact of polymorphism in the hepatitis B surface gene on human leukocyte antigen (HLA) class II
por: Choga, W -T, et al.
Publicado: (2019)

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †
por: Seatla, Kaelo K., et al.
Publicado: (2021)

Unintended pregnancy, contraceptive use, and childbearing desires among HIV-infected and HIV-uninfected women in Botswana: across-sectional study
por: Mayondi, Gloria K., et al.
Publicado: (2016)

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana
por: Kotokwe, Kenanao, et al.
Publicado: (2023)

No Difference in Antibody Responses to Tetanus Vaccine Among HIV-Exposed and -Unexposed Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2017)

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay
por: Rantshabeng, Patricia, et al.
Publicado: (2019)

Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2023)

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
por: Moraka, Natasha O., et al.
Publicado: (2023)

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
por: Mokaleng, Baitshepi, et al.
Publicado: (2023)

2529. Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations with 24-Month Growth and Neurodevelopment
por: Moraka, Natasha Onalenna, et al.
Publicado: (2019)

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use
por: Maruapula, Dorcas, et al.
Publicado: (2023)

Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya
por: Tawe, Leabaneng, et al.
Publicado: (2022)

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
por: Rantshabeng, Patricia S., et al.
Publicado: (2017)

Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2021)

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana
por: Powis, Kathleen M, et al.
Publicado: (2017)

Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2021)

Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls
por: Mosepele, Mosepele, et al.
Publicado: (2017)

Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples
por: Seatla, Kaelo K., et al.
Publicado: (2019)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
por: Bareng, Ontlametse T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_04ljjnr04536vumo2mpbiu2d1e